Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
- PMID: 12200775
- DOI: 10.1053/jlts.2002.34892
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
Abstract
We previously proposed modified staging criteria for predicting acceptable outcome after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). These were solitary tumor < or = 6.5 cm, or three or fewer nodules with the largest lesion < or = 4.5 cm and total tumor diameter < or = 8 cm, without gross vascular invasion (University of California, San Francisco [UCSF] criteria). In this study, we further evaluated the performance of the Milan criteria (solitary tumor < or = 5 cm, or three or fewer lesions none > 3 cm), the UCSF criteria, and the Pittsburgh modified tumor-node-metastasis (TNM) criteria. Pathologic HCC staging according to each set of criteria was performed in 70 patients. The difference in survival when comparing 24 patients with HCC exceeding Milan criteria versus 46 patients meeting Milan criteria did not reach statistical significance (HR, 2.0; P = .12). Using our definition for acceptable 2-year survival to be > or = 70%, the 14 patients (20%) meeting UCSF criteria but exceeding Milan criteria had a 2-year survival of 86% (95% CI, 54% to 96%). Survival for Pittsburgh stage I, II, and IIIA patients as a group was significantly better than for stages IIIB and IVA patients combined (HR, 4.2; P = .007), and similar to survival for patients meeting UCSF criteria. Advanced tumor exceeding UCSF criteria served reasonably well as a surrogate marker for poorly differentiated grade and microvascular invasion. In conclusion, our analyses suggest that UCSF criteria better predict acceptable posttransplant outcome than Milan criteria. UCSF criteria confer a different advantage over Pittsburgh criteria, which require information on microvascular invasion that is difficult to ascertain preoperatively without the attendant risk of biopsy.
Similar articles
-
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.Liver Transpl. 2006 Dec;12(12):1761-9. doi: 10.1002/lt.20884. Liver Transpl. 2006. PMID: 16964590
-
Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.Liver Transpl. 2004 Nov;10(11):1343-54. doi: 10.1002/lt.20311. Liver Transpl. 2004. PMID: 15497158
-
Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.Liver Transpl. 2007 Apr;13(4):543-51. doi: 10.1002/lt.21078. Liver Transpl. 2007. PMID: 17394152
-
Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.Curr Opin Organ Transplant. 2008 Jun;13(3):234-40. doi: 10.1097/MOT.0b013e3282fc2633. Curr Opin Organ Transplant. 2008. PMID: 18685309 Review.
-
Liver transplantation exceeding UCSF criteria: case report of a late recurrence treated by surgery and review of the literature.Eur Surg Res. 2010;44(1):52-5. doi: 10.1159/000264635. Epub 2009 Dec 4. Eur Surg Res. 2010. PMID: 19996598 Review.
Cited by
-
A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.Cureus. 2020 Jul 14;12(7):e9191. doi: 10.7759/cureus.9191. Cureus. 2020. PMID: 32818122 Free PMC article. Review.
-
Optimal treatment for hepatocellular carcinoma in the cirrhotic liver.Ann R Coll Surg Engl. 2009 Oct;91(7):545-50. doi: 10.1308/003588409X464649. Ann R Coll Surg Engl. 2009. PMID: 19833013 Free PMC article. No abstract available.
-
Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.World J Gastroenterol. 2011 Apr 14;17(14):1848-57. doi: 10.3748/wjg.v17.i14.1848. World J Gastroenterol. 2011. PMID: 21528059 Free PMC article.
-
FOXC1, the new player in the cancer sandbox.Onco_target. 2017 Nov 28;9(8):8165-8178. doi: 10.18632/onco_target.22742. eCollection 2018 Jan 30. Onco_target. 2017. PMID: 29487724 Free PMC article. Review.
-
Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.Gastroenterol Hepatol (N Y). 2020 Oct;16(10):506-516. Gastroenterol Hepatol (N Y). 2020. PMID: 34017223 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical